about
Tuberculosis treatment in patients with comorbiditiesRelationship between blood levels of heavy metals and lung function based on the Korean National Health and Nutrition Examination Survey IV-VPerformance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated populationSevere pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.Comparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumoniaHealthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis.Increased prevalence of self-reported asthma among Korean adults: an analysis of KNHANES I and IV data.Tuberculin skin test and boosted reactions among newly employed healthcare workers: an observational study.Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 productionEvaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts.Comparison of CT-Determined Pulmonary Artery Diameter, Aortic Diameter, and Their Ratio in Healthy and Diverse Clinical Conditions.Elevated serum C-reactive protein as a prognostic marker in small cell lung cancerPrognostic Implications of Serum Lipid Metabolism over Time during SepsisPrognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinibEGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI.Urine Cotinine for Assessing Tobacco Smoke Exposure in Korean: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES).Endobronchial metastases from extrathoracic malignancyRisk factors for tuberculosis after gastrectomy in gastric cancer.Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD.Pharmacogenomic assessment of outcomes of pemetrexed-treated patients with adenocarcinoma of the lung.Impact of toxocariasis in patients with unexplained patchy pulmonary infiltrate in Korea.Risk factors and outcome of primary graft dysfunction after lung transplantation in Korea.The Risk Factors and Characteristics of COPD Among Nonsmokers in Korea: An Analysis of KNHANES IV and V.Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease.Association between genetic variants in the IRGM gene and tuberculosis in a Korean population.Sarcoidosis presenting with massive pleural effusion and elevated serum and pleural fluid carbohydrate antigen-125 levels.Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus.Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling.Antibiotic treatment for nontuberculous mycobacterial lung disease.Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest.Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease.EphA2 Receptor Signaling Mediates Inflammatory Responses in Lipopolysaccharide-Induced Lung InjuryFactors associated with the quality of life of Korean COPD patients as measured by the EQ-5D.Glucagon levels, disease severity, and outcome in severe sepsis.Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
P50
Q27005748-D772C1C4-E382-4E33-B274-EA31725B0BEDQ28385451-F7085E04-795B-42A1-BA19-39087BDADB36Q33518054-77B3A5A6-AAD1-4190-AB3D-1373DADE6C19Q33691650-C8D5912E-3FFB-4ECC-8143-C9CCECA2C552Q33822603-8B29E05D-8B47-48ED-BC70-1E9BC468F683Q33843896-EE8C033F-BA64-4033-AA2B-B13F4BCB3E07Q34062904-CE9CCB97-68F4-406D-B2C2-CDAE493F3E40Q34617997-67999742-68EE-4302-AEFA-6E775B8F733FQ34746065-3C5388A0-1BD1-4A51-8E22-27C803488CD8Q34928386-904F8A94-E775-4343-89AA-C1BC2D897E28Q34983098-4924AA81-57BA-4FF3-B28A-47064CE7BE27Q35331571-85685F5F-FE81-4057-9A97-57504AA7E3C1Q35587727-3590AD61-80CF-437D-ACE4-E677547DA9E2Q35648199-0C5400B8-A92C-4438-A5A0-3851908FBD09Q36006620-C0DAB5D4-109B-4DC4-9EB0-63AB1FC12B48Q36230768-FDC8382C-2281-41FE-B753-041ACFB7162AQ36348040-C5CB2756-769D-4DD1-9103-7989520E218CQ36381061-9746F7E3-9FF5-4035-87DF-A1E8DC6C54A7Q36620403-88485791-5CEC-4326-9948-B43CCB4080FCQ36621528-457F3969-2B56-424E-9F50-715283E1885EQ36787740-AA0C15FD-C639-429D-B35F-49EA21ABFA97Q36872919-39AC1A85-8108-47A1-82EB-F5805666C375Q37116783-206FA19B-F4F9-4E65-81C2-FC151C2E76B9Q37528243-CDA5685E-533D-4DCB-B0AF-D16F443DF1BBQ38415716-E8524CE5-8E2F-4C06-82FB-DB2B77448713Q38437471-FDA6DCE8-C8B2-472F-8C7E-C8FC26E179EDQ38440865-CC5A521B-06AB-4DF3-8349-5CADE2A6A760Q38454306-66095C97-44DD-44D8-B228-3857A902EFE5Q38564098-F4868067-D0D6-4D7B-99C9-DB6FE669D376Q38661516-D43557DD-B573-4595-A886-B06498956600Q38661726-03924F24-3B3D-4CA0-B12B-F818DB505AFCQ38770072-C86B461B-D04C-4593-B81C-F983C2D8B056Q38968644-0700124B-83AF-4F4C-BB71-09805A1CA802Q40282377-0460D0B0-641E-45AC-93B2-37AFDDA46FECQ40766691-2DDE3591-5C8A-4EB9-82C6-9BC248C9C46AQ40892099-BE6740B2-9665-470B-951E-03EE21315008Q41114117-89D7C5F4-69DE-4C07-8756-E6B3ED8A7CFEQ41115481-63113A2B-3BCA-495C-9ED8-6E9FFAA23C7BQ41227638-B0EF8D6B-491F-4017-9026-970ABA3D90BEQ41589188-596409EB-C0BD-4579-AE82-569091A25E89
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Young Ae Kang
@ast
Young Ae Kang
@en
Young Ae Kang
@es
Young Ae Kang
@nl
type
label
Young Ae Kang
@ast
Young Ae Kang
@en
Young Ae Kang
@es
Young Ae Kang
@nl
prefLabel
Young Ae Kang
@ast
Young Ae Kang
@en
Young Ae Kang
@es
Young Ae Kang
@nl
P31
P496
0000-0002-7783-5271